The Role of Pull Incentives in Addressing Antim...

By HEOR Staff Writer

June 26, 2024

Introduction Antimicrobial resistance (AMR) is a growing global health threat. According to rece...
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Biosimilar Competition and Patient Out-of-Pocket Costs
Insights into Austria’s Pricing and Pharmaceutical Policy
COPD Management: Evidence Report on Ensifentrine
Economics in Clinical Trials: A Guide to Value-Based Decisions
A Cost-Effectiveness Analysis of Emicizumab Treatment in Non-Severe Haemophil...
Evaluating the Impact of Molnupiravir in COVID-19 Treatment